PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM
Clinical trial NCT06788171 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06788171
- Sponsor
- Fujian Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2026-12-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.